Entrada Therapeutics, Inc.

TRDA · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$93,286$72,482$67,837$101,211
Short-Term Investments$233,552$281,530$314,678$318,787
Receivables$3,196$1,180$2,044$3,680
Inventory$0$0$0$0
Other Curr. Assets$8,223$13,954$18,634$16,361
Total Curr. Assets$338,257$369,146$403,193$440,039
Property Plant & Equip (Net)$70,528$75,488$79,097$82,048
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$3,950$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$163$4,149$4,189$4,234
Total NC Assets$74,641$79,637$83,286$86,282
Other Assets$0$0$0$0
Total Assets$412,898$448,783$486,479$526,321
Liabilities
Payables$3,166$1,857$2,188$4,259
Short-Term Debt$4,350$5,462$6,510$7,559
Tax Payable$0$0$802$667
Deferred Revenue$351$689$1,352$13,654
Other Curr. Liab.$16,152$11,795$7,579$13,343
Total Curr. Liab.$24,019$19,803$18,431$39,482
LT Debt$48,050$49,281$50,487$51,648
Deferred Rev, NC$113$194$301$6,513
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$48,163$49,475$50,788$58,161
Other Liabilities$0$0$0$0
Cap. Leases$48,050$54,743$56,997$59,207
Total Liabilities$72,182$69,278$69,219$97,643
Equity
Pref Stock$0$0$0$0
Common Stock$4$4$4$4
Retained Earnings-$233,930-$189,796-$146,693-$129,344
AOCI$621$400$437-$43
Other Equity$574,021$568,897$563,512$558,061
Total Equity$340,716$379,505$417,260$428,678
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$412,898$448,783$486,479$526,321
Net Debt-$40,886-$17,739-$10,840-$42,004